Clinical Trials in Seattle

Showing 1361-1380 of 4,491 trials

Acute Exercise Intervention in Breast Cancer Survivors

NCT03779867

This trial studies how a 45-minute bout of acute exercise in women with a history of breast cancer can affect factors associated with breast cancer and help doctors learn more about how exercise can help prevent breast cancer. In an earlier part of the study, investigators looked at the effects of the same intervention in women without a history of cancer.

Breast Carcinoma

Fred Hutchinson Cancer Center112 participantsStarted Mar 2019

Seattle, Washington, United States

COMPLETEDPhase 2/3< 1 mile

Novel Experimental COVID-19 Therapies Affecting Host Response

NCT04924660

The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients hospitalized for COVID-19 include hastening recovery and preventing progression to critical illness, multiorgan failure, or death. Our objective is to determine whether modulating the host tissue response improves clinical outcomes among patients with COVID-19. The primary analysis will include data from NCT05593770.

COVID-19SARS-CoV-2 InfectionCoronavirus Infection

Sean Collins1,060 participantsStarted Jul 2021

Birmingham, Alabama, United States • Chandler, Arizona, United States • Los Angeles, California, United States +48 more locations

Acute Exercise Intervention in Breast Cancer Survivors

Novel Experimental COVID-19 Therapies Affecting Host Response

Find Trials by Condition in Seattle

International EXPAND Heart Pivotal Trial

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

Emergency Department-Initiated Buprenorphine Validation Network Trial

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response

Dupixent Study for Alternate Administration

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

A Study of TAK-861 in Participants With Narcolepsy Type 2